Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with heart failure (Stage A/B, with preserved pumping function):
- People who have been formally diagnosed with heart failure where the heart's pumping function is preserved (pumping more than 50% of blood out with each beat)
- People whose condition has been stable for at least 3 months, with no hospital admissions during that time
- People aged 65 or older
- People who are willing to sign a written consent form to take part in the study
For people with heart failure (Stage C/D, with either preserved or reduced pumping function):
- People who have been formally diagnosed with heart failure where the heart either pumps well (over 50%) or pumps weakly (under 40%)
- People whose condition has been stable for at least 3 months, with no hospital admissions during that time
- People aged 65 or older
- People who are willing to sign a written consent form to take part in the study
For healthy volunteers:
- People aged 18 or older
- People who are able to provide written consent to participate
For people with Type 2 diabetes (without symptoms):
- People aged 18 to 75
- People with a confirmed, stable Type 2 diabetes diagnosis, recorded by a doctor or confirmed through a specific blood sugar test or a blood marker called HbA1c at 6.5% or above
Who may not be able to join:
For people with heart failure:
- People who have a medical reason why they cannot safely have an MRI scan
- People who are unable to walk or complete a 6-minute walking test
- People who have a nerve or muscle condition that could affect muscle assessment, such as motor neurone disease, multiple sclerosis, muscle disorders, or muscle inflammation
- People who regularly or occasionally take steroid tablets by mouth
- People who have an untreated overactive or underactive thyroid
- People who have been hospitalised due to heart failure in the past 3 months
For healthy volunteers:
- People who have had, or currently show, any signs of heart failure
- People who have risk factors known to be associated with developing heart failure, such as high blood pressure, diabetes, or coronary artery disease
For people with Type 2 diabetes (without symptoms):
- People who experience chest pain (angina) or significant breathlessness limiting daily activity
- People who have significant artery disease, such as a history of heart attack, previous procedures to open blocked arteries, stroke, mini-stroke, or circulation problems in the limbs
- People who have an irregular heart rhythm known as atrial fibrillation or flutter
- People who have moderate to severe heart valve disease
- People who have a history of heart failure or a condition affecting the heart muscle
- People who have Type 1 diabetes
- People whose blood test results suggest they may actually have a form of Type 1 diabetes that developed in adulthood
- People with moderate to severe kidney disease (confirm with trial site for exact measurement details)
- People who have a medical reason why they cannot safely have an MRI scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gerry McCann, BSc, MB, ChB, MRCP, MD, University of Leicester (UoL)
Phone: 44 (0)116 204 4786
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Volumetric quadriceps skeletal muscle mass (cm^3)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.